Hepatitis C virus (HCV) infection of Huh‐7.5 hepatoma cells results in focal areas of infection
where transmission is potentiated by cell‐cell contact. To define route(s) of transmission, …

The mechanism underlying the impaired immune response to hepatitis B vaccines in up to
10% of healthy subjects is not known. An increased incidence of poor responsiveness in …

Little is known about the duration and protective capacity of the humoral immune response
to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In studies from Iceland1 …

The viral life cycle of the hepatitis C virus (HCV) has been studied mainly using different in
vitro cell culture models. Studies using pseudoviral particles (HCVpp) and more recently cell …

Large-scale serosurveillance of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)
will only be possible if serological tests are sufficiently reliable, rapid and …

Endstage liver disease caused by chronic hepatitis C virus (HCV) infection is the leading
indication for liver transplantation in the Western world. However, immediate reinfection of the …

Control of hepatitis C virus (HCV) infection remains a huge challenge of global medical
importance. Using a variety of in vitro approaches, neutralizing antibodies (nAbs) have been …

The role of the humoral immune response in the natural course of hepatitis C virus (HCV)
infection is widely debated. Most chronically infected patients have immunoglobulin G (IgG) …

Background Factors affecting response to SARS-CoV-2 mRNA vaccine in allogeneic
hematopoietic stem cell transplantation (allo-HCT) recipients remain to be elucidated. Methods …

A formulation of recombinant hepatitis B surface antigen (HBsAg) combined with a novel
adjuvant system, SBAS4—a combination of aluminium salt and monophosphoryl lipid A (MPL), …